TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Regulatory Work to Secure Licence Variation for anastrozole

Pharmaceutical products
Pharmacy services
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "Regulatory Work to Secure Licence Variation for anastrozole". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS EnglandScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
39.4Bids / Report
5.2% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 312 active published awards; 310 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS England
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published27 May 2022, 16:48 BST
Last source update27 May 2022, 16:48 BST
Recurring procurementNot published
ClassificationPharmaceutical products, Pharmacy services
Delivery area
UK
OCIDocds-h6vhtk-02de26
What is being bought
This Tender is solely for the work involved to apply for and implement a major (type II) MHRA Marketing Authorisation variation to add a new clinical indication for anastrozole. The successful Bidder will be responsible for ensuring that all relevant MHRA conditions and documentation for the Marketing Authorisation variation are met and submitted within the time limits agreed with the Authority. In return the Authority will fund actual and reasonably incurred costs associated with obtaining this licence variation only.
What changed
From the official release history
  1. tender value changed
    27 May 2022, 16:48 BST
  2. Status changed to complete
    27 May 2022, 16:48 BST
  3. Official notice release published
    27 May 2022, 16:48 BST
  4. Submission deadline changed to published date
    27 May 2022, 16:48 BST
  5. Published value updated to £1
    19 Jan 2022, 17:30 GMT
  6. Status changed to active
    19 Jan 2022, 17:30 GMT
  7. Status changed to published status
    19 Jan 2022, 17:30 GMT
  8. Official notice release published
    19 Jan 2022, 17:30 GMT
  9. Official notice release published
    19 Jan 2022, 17:30 GMT
  10. Submission deadline changed to 31 Jan 2022, 13:00 GMT
    19 Jan 2022, 17:30 GMT
  11. Status changed to planned
    7 Sept 2021, 19:14 BST
  12. Official notice release published
    7 Sept 2021, 19:14 BST
  13. Buyer information updated
    7 Sept 2021, 19:14 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    This Tender is solely for the work involved to apply for and implement a major (type II) MHRA Marketing Authorisation variation to add a new clinical indication for anastrozole. The successful Bidder will be responsible for ensuring that all relevant MHRA conditions and documentation for the Marketing Authorisation variation are met and submitted within the time limits agreed with the Authority. In return the Authority will fund actual and reasonably incurred costs associated with obtaining this licence variation only. Additional information: Price was not the only award criterion and all criteria were stated in the procurement documents
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    27 May 2022, 16:48 BST
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 28 Apr 2022, 00:00 BST · Not published
Commercial outcome and competition
Awards
Accord-UK Ltd
Not published · Not published · active
Contracts
Contract
Not published · signed 28 Apr 2022, 00:00 BST · active
Bid statistics
bids: 3 (lot 1)
electronicBids: 3 (lot 1)
foreignBidsFromEU: 3 (lot 1)
highestValidBidValue: 1 (lot 1)
lowestValidBidValue: 1 (lot 1)
Buyer and organisations in this procedure

NHS England

Contracting authority GB-FTS-3717
View buyer profile

  • NHS England
    buyer

    Quarry House, Leeds, UKE, LS2 7UE
    liz.fleetwood1@nhs.net

  • Accord-UK Ltd
    supplier

    79585
    Whiddon Valley, Barnstaple, Devon, EX32 8NS, Barnstaple, UK, EX32 8NS

  • NHS England
    reviewBody

    Quarry House, Quarry Hill, Leeds, LS2 7UE
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published